This transcript has been edited for clarity.Kathrin LaFaver, MD: Hello, and welcome, on behalf of Medscape. My name is Dr Kathrin LaFaver. I'm a neurologist in Saratoga Springs, New York. I have the great pleasure today to have two interview guests. Our topic today is administrative burdens and prior authorizations in neurology. With me today are Dr Bruce Cohen, who's a pediatric neurologist in Akron, Ohio, and the chair of the AAN Advocacy Committee. We also have Matt Kerschner, who is director of regulatory affairs and policy for the American Academy of Neurology (AAN). Welcome.Matt Kerschner: Thank you.Bruce H. Cohen, MD: Thank you.LaFaver: We'll jump right in. Now, as we know, administrative burdens have exponentially increased in medicine, and that includes insurance requirements such as prior authorizations to get medications or procedures covered. Could you give us an overview of the scope of this problem and how it affects neurology as a specialty? Dr Cohen?Prior Authorization, Delays in Care, and Treatment AbandonmentCohen: The burdens of prior authorization are highly significant and harm patient access to care. This process is time-consuming for practices and frustrating and confusing for the patients seeking this care. It results in delays in care often.Some of the work can be offloaded by my nursing staff, but some of this requires my time, and that's time away from my patients. We see this impact the care of the people with neurologic disorders, including the need to perform neuroimaging, as well as get prescription medication for common diseases like multiple sclerosis and migraine. In nearly all instances, the items requested meet the prior authorization request, as it exists already in the medical record.It impacts our workflow every day. According to data released by the American Medical Association (AMA), 95% of physicians report that prior authorization leads to delays in necessary care, with more than 1 in 4 physicians reporting that prior authorization has led to serious adverse events in their patients. Within the practice of neurology, delays in care can lead to otherwise unavoidable disease exacerbation. This often occurs in illnesses like multiple sclerosis, resulting in a litany of adverse outcomes ranging from loss of driving privileges to hospitalization, emergency department visits, permanent disability, and even death.Prior authorization and other utilization management policies can have a disparate impact on beneficiaries with limited digital access, limited English proficiencies, cognitive impairment, or caregiver constraints, which are all common among patients with neurologic disorders.It also disproportionately hurts small and rural practices. For specialties like neurology that already face significant workforce challenges, prior authorization strains the neurology workforce. According to the AMA data, practices complete an average of 40 prior authorization requests every week, and this requires them or their staff to spend 13 hours a week on completing these unnecessary tasks.This obviously reduces the time we have to spend with our patients and worsens already extensive wait times.Furthermore, prior authorization contributes to burnout, with 94% of physicians reporting that prior authorization somewhat or significantly increases their burnout. It's interesting that when I get on the phone with a physician working for the insurance company for us to figure out and for me to convince them to do what I wanted to do in the first place, I almost always get what my patients need. My arguments have already been documented in the medical record, so it's a waste of my time.LaFaver: Thanks for outlining this so clearly and touching on many important topics where this really plays significant roles in our practice. Mr Kerschner, is there anything else you want to add regarding what consequences this ultimately has for our patients?Kerschner: The data are very clear here that prior authorization delays clinically necessary care and can even result in care abandonment. In the survey that Dr Cohen was referencing, 79% of physicians surveyed indicated that prior authorization has led to treatment abandonment.Step therapy also adds some nuance here, and can also lead to less effective care, as patients are required to fail first on a potentially less effective medication before receiving the medication that was initially prescribed by their physician, or their physician knows is appropriate for them in the first place.We know this can lead to irreversible disease progression as well as a number of adverse outcomes, including increased hospitalizations, emergency department visits, and disability, all those sorts of things that otherwise would have been avoided if we'd just given the patient what their physician prescribed in the first place.How Is the AAN Easing the Burden?LaFaver: Absolutely. Both of you are part of the AAN Advocacy Committee, so thank you for this important work. Can you let us know what the AAN is doing specifically to help ease these administrative burdens on practices, especially as it comes to prior authorizations?Kerschner: Yes, absolutely. The AAN is a very strong advocate for reform at both the federal and state level, speaking before Congress and the administrative agencies, in support of a whole suite of reforms to ease administrative burdens, particularly as they relate to prior authorization.We, along with the broader house of medicine, have been working strongly in support of the Improving Seniors' Timely Access to Care Act, which would implement a number of crucial guardrails on how Medicare Advantage plans use and implement prior authorization. This legislation was voted unanimously out of both the House Ways and Means and Energy and Commerce Committees recently. We're very, very excited that this crucial legislation cleared those hurdles, and we're hopeful that it could be included in a year-end legislative package.We're also strong supporters of the Safe Step Act, which is legislation that would establish a number of common sense exceptions to step therapy protocols implemented by employer-based plans. We've also commented in support of a number of administrative agency actions to implement things like electronic prior authorization capabilities across plan types, reduce wait times, improve plan communications on prior authorization decisions to providers.At the state level, we have pushed a whole suite of reforms that mirror those that we're pushing at the federal level but also have been particularly active on reining in the use of AI in prior authorization to ensure that there is a human in the loop and that care isn't just algorithmically denied without a physician or a human expert in the loop at some point.LaFaver: That's really good to hear that there are many, many efforts underway. Then, of course, you guys have many options for neurologists who get involved. Dr Cohen, could you tell us, if someone is interested in taking action toward affecting changes, how can they get involved?Cohen: Neurologists need to make sure that the legislators hear from them in support of crucial reforms aimed at improving patient access and reducing administrative burdens. In just a few clicks through the AAN's Advocacy Action Center, neurologists can send letters to their senators and their representatives in support of both the Improving Seniors' Timely Access to Care Act and the Safe Step Act, urging the senators and representatives to take action before the end of the current Congress.It's through our collective voice and consistently raising this issue with the policymakers that we'll be able to achieve the long-term reforms needed to protect patient access to high-quality neurologic care.LaFaver: Of course, there are events like AAN's Neurology on the Hill. I don't know if you want to talk a little bit toward that.Cohen: Neurology on the Hill is the highlight of our late winter activities in the AAN. This is where approximately 200 neurologists throughout the country — we try to get at least someone from every state to participate — lobby the Hill on a day, and speak with their senators and representatives, where we discuss issues just like this with them face to face. We also do something called Neurology off the Hill, which is an August event, where we visit our representatives in their own home offices. That's very fun.AI to the Rescue?LaFaver: Wonderful. We'll link these events and issues in the show notes so people can really take the next step and find out more if they don't know about these things already. I have one more question. Where do you see the future headed as it comes to these administrative tasks? As Mr Kerschner was commenting, AI has bigger and bigger roles for insurance companies now, and automatic denials are more and more commonplace. How can we maybe use AI on the flip side to possibly create positive changes for our practices?Cohen: I think that's a great question and a great point. When AI is used properly, the idea is that it can lessen the cost of neurologic care. By getting patients treated faster with the right therapy, we can do that. AI can sniff through the chart in a microsecond, looking for the questions that I would have to get on the phone to provide, often, to get the prior authorization approved. The answers to those questions are in the chart. I've already written why I want this test performed or why I want this medication. AI can really benefit all of us if used for good.LaFaver: Very well said. Mr Kerschner, anything else to add?Kerschner: I would really defer to Dr Cohen as the clinician on this one. Of course, we are going to continue to fight to make sure that there are robust guardrails in place so that insurers cannot inappropriately use AI to inappropriately deny care. That's going to remain a top priority for us at both the federal and state level, knowing that this is a concerning emerging trend that we're really trying to get ahead of.LaFaver: Absolutely. Thank you both for your time and your enlightening answers on this important topic. It's really an appeal to any neurologist and everyone to get engaged and really help us secure a better future for our field and for our patients, ultimately. Thanks again for joining us today, and have a good rest of your day, everyone.Kerschner: Thank you.Cohen: Thank you.
Easing the Burden of Prior Authorizations in Neurology
Full Article
Original Source
Read the full article at Medscape →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.